Monoclonal gammopathy missed by capillary zone electrophoresis

被引:5
作者
Schild, Christof [1 ,2 ]
Egger, Florence [1 ,2 ]
Kaelin-Lang, Alain [3 ]
Nuoffer, Jean-Marc [1 ,2 ]
机构
[1] Univ Hosp Bern, Inselspital, Inst Clin Chem, CH-3010 Bern, Switzerland
[2] Univ Bern, Bern, Switzerland
[3] Univ Hosp Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland
关键词
capillary zone electrophoresis; gammopathy; monoclonal components; monoclonal proteins; PROTEIN QUANTIFICATION; INTERFERENCE; CRITERIA; ASSAYS;
D O I
10.1515/CCLM.2011.189
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Serum protein electrophoresis is used as a screening test for monoclonal gammopathies. Here, we present a case of a high-concentration monoclonal immunoglobulin (M-protein) that was missed by serum protein electrophoresis on a Capillarys 2 capillary zone electrophoresis system. The aim of our study was to identify the reason for the failure of the system to detect the M-protein. Methods: M-protein solubility was examined in response to temperature, pH, ionic strength, the chaotropic agent urea and the reducing agent 2-mercaptoethanol. Results: Precipitation of the M-protein was not cold-induced, but solubility decreased at pH 8.5 or higher, when the pH approached the apparent isoelectric point. The M-protein also precipitated in alkaline Capillarys 2 electrophoresis buffer (pH 10), which was the reason for the false-negative electrophoresis result. Precipitation of the M-protein was not related to the ionic strength of the buffer. Solubility improved in presence of urea. Pre-treatment of serum with 2-mercaptoethanol revealed the missing M-protein peak of 36 g/L on the electropherogram. Conclusions: This case shows that insolubility of M-proteins in alkaline buffer is one possible cause of false-negative results on capillary zone electrophoresis systems. False-negative results should be considered, especially when accompanying laboratory results are inconsistent with the electropherogram.
引用
收藏
页码:1217 / 1219
页数:3
相关论文
共 15 条
[1]  
AIZAWA Y, 1979, Clinical and Experimental Immunology, V37, P267
[2]   Gammopathy interference in clinical chemistry assays: mechanisms, detection and prevention [J].
Bakker, Andries J. ;
Muecke, Matthias .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2007, 45 (09) :1240-1243
[3]  
Bossuyt X, 2001, CLIN CHEM, V47, P1477
[4]   International uniform response criteria for multiple myeloma [J].
Durie, B. G. M. ;
Harousseau, J-L ;
Miguel, J. S. ;
Blade, J. ;
Barlogie, B. ;
Anderson, K. ;
Gertz, M. ;
Dimopoulos, M. ;
Westin, J. ;
Sonneveld, P. ;
Ludwig, H. ;
Gahrton, G. ;
Beksac, M. ;
Crowley, J. ;
Belch, A. ;
Boccadaro, M. ;
Turesson, I. ;
Joshua, D. ;
Vesole, D. ;
Kyle, R. ;
Alexanian, R. ;
Tricot, G. ;
Attal, M. ;
Merlini, G. ;
Powles, R. ;
Richardson, P. ;
Shimizu, K. ;
Tosi, P. ;
Morgan, G. ;
Rajkumar, S. V. .
LEUKEMIA, 2006, 20 (09) :1467-1473
[5]  
Henskens Y, 1998, CLIN CHEM, V44, P1184
[6]  
Jenkins MA, 1996, CLIN CHEM, V42, P1886
[7]   Screening Panels for Detection of Monoclonal Gammopathies [J].
Katzmann, Jerry A. ;
Kyle, Robert A. ;
Benson, Joanne ;
Larson, Dirk R. ;
Snyder, Melissa R. ;
Lust, John A. ;
Rajkumar, S. Vincent ;
Dispenzieri, Angela .
CLINICAL CHEMISTRY, 2009, 55 (08) :1517-1522
[8]  
Keren DF, 2001, CLIN CHEM, V47, P1326
[9]   How paraproteins can affect laboratory assays: spurious results and biological effects [J].
King, Richard I. ;
Florkowski, Christopher M. .
PATHOLOGY, 2010, 42 (05) :397-401
[10]   Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia:: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia [J].
Kyle, RA ;
Treon, SP ;
Alexanian, R ;
Barlogie, B ;
Björkholm, M ;
Dhodapkar, M ;
Lister, TA ;
Merlini, G ;
Morel, P ;
Stone, M ;
Branagan, AR ;
Leblond, W .
SEMINARS IN ONCOLOGY, 2003, 30 (02) :116-120